Standex International (SXI) Financials

$158.98 +14.13 (+9.75%)

Closing price 05/2/2025 03:59 PM Eastern

Extended Trading

$159.04 +0.06 (+0.04%)

As of 05/2/2025 05:34 PM Eastern

Annual Income Statements for Standex International

This table shows Standex International's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	6/30/2014	6/30/2015	6/30/2016	6/30/2017	6/30/2018	6/30/2019	6/30/2020	6/30/2021	6/30/2022	6/30/2023	6/30/2024
Net Income / (Loss) Attributable to Common Shareholders	43	55	52	47	37	68	20	36	61	139	73
Consolidated Net Income / (Loss)	43	55	52	47	37	68	20	36	61	139	73
Net Income / (Loss) Continuing Operations	50	55	52	39	30	48	41	39	61	139	74
Total Pre-Tax Income	68	76	69	51	68	67	54	53	81	164	95
Total Operating Income	66	79	70	57	78	79	61	59	88	171	102
Total Gross Profit	238	247	252	216	226	235	215	241	270	285	282
Total Revenue	716	772	752	648	596	640	605	656	735	741	721
Operating Revenue	716	772	752	648	596	640	605	656	735	741	721
Total Cost of Revenue	478	525	499	432	370	405	389	415	465	456	439
Operating Cost of Revenue	478	525	499	432	370	405	389	415	465	456	439
Total Operating Expenses	172	169	182	159	148	155	155	182	182	114	180
Selling, General & Admin Expense	166	166	170	145	141	150	148	163	170	172	170
Other Operating Expenses / (Income)	-3.46	-0.44	7.46	0.00	0.00	0.50	0.00	0.00	5.75	-0.61	0.11
Restructuring Charge	10	3.44	4.23	14	7.18	4.36	6.43	4.41	6.02	4.39	11
Other Special Charges / (Income)	-	-	-	-	-	-	-	15	0.00	-62	-0.27
Total Other Income / (Expense), net	1.94	-2.53	-1.82	-5.96	-9.75	-13	-6.45	-6.47	-7.01	-7.14	-6.62
Interest Expense	2.25	3.16	2.87	4.04	8.03	11	7.48	5.99	5.87	5.41	4.54
Other Income / (Expense), net	4.18	0.63	1.05	-1.92	-1.72	-1.74	1.02	-0.47	-1.13	-1.74	-2.07
Income Tax Expense	18	21	16	12	38	19	13	14	20	25	22
Net Income / (Loss) Discontinued Operations	-6.88	-0.50	-0.17	7.41	6.24	20	-21	-2.07	-0.09	-0.16	-0.52
Basic Earnings per Share	$3.39	$4.33	$4.11	$3.68	$2.88	$5.40	$1.64	$3.00	$5.13	$11.77	$6.22
Weighted Average Basic Shares Outstanding	12.61M	12.66M	12.68M	12.67M	12.70M	12.45M	12.38M	12.21M	11.97M	11.85M	11.85M
Diluted Earnings per Share	$3.35	$4.27	$4.08	$3.65	$2.86	$5.38	$1.63	$2.97	$5.06	$11.58	$6.14
Weighted Average Diluted Shares Outstanding	12.61M	12.66M	12.68M	12.67M	12.70M	12.45M	12.38M	12.21M	11.97M	11.85M	11.85M
Weighted Average Basic & Diluted Shares Outstanding	12.61M	12.66M	12.68M	12.67M	12.70M	12.45M	12.38M	12.21M	11.97M	11.85M	11.85M
Cash Dividends to Common per Share	$0.38	$0.46	-	-	$0.70	$0.78	$0.86	$0.94	$1.02	$1.10	$1.18

This table shows Standex International's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025
Period end date	6/30/2022	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	13	18	20	81	20	19	19	16	20	18	0.86
Consolidated Net Income / (Loss)	13	18	20	81	20	19	19	16	20	18	1.28
Net Income / (Loss) Continuing Operations	13	18	20	81	20	19	19	16	20	18	1.29
Total Pre-Tax Income	17	24	26	86	27	25	24	20	26	23	2.00
Total Operating Income	19	26	28	89	28	27	26	22	27	24	8.46
Total Gross Profit	67	68	72	71	74	73	72	68	69	70	71
Total Revenue	185	181	188	184	188	185	178	177	180	170	190
Operating Revenue	185	181	188	184	188	185	178	177	180	170	190
Total Cost of Revenue	118	112	115	113	115	112	107	109	111	100	118
Operating Cost of Revenue	118	112	115	113	115	112	107	109	111	100	118
Total Operating Expenses	47	42	45	-18	45	46	46	46	42	46	63
Selling, General & Admin Expense	41	41	44	43	45	44	43	42	41	43	46
Restructuring Charge	1.99	0.87	0.69	2.26	0.57	2.41	2.56	4.57	1.29	2.93	17
Other Special Charges / (Income)	-	-	0.00	-62	-	-	-	0.00	-	-	0.00
Total Other Income / (Expense), net	-1.87	-2.21	-1.50	-2.16	-1.28	-2.12	-1.35	-1.58	-1.57	-0.95	-6.47
Interest Expense	1.39	1.19	1.57	1.42	1.24	1.28	1.02	0.95	1.30	0.98	5.58
Other Income / (Expense), net	-0.48	-1.02	0.07	-0.75	-0.04	-0.85	-0.33	-0.63	-0.27	0.03	-0.89
Income Tax Expense	4.13	5.77	6.23	5.79	7.01	5.90	5.41	4.33	5.89	4.96	0.71
Net Income / (Loss) Discontinued Operations	0.05	-0.05	-0.04	-0.06	-0.02	-0.08	-0.20	-0.14	-0.10	0.01	-0.01
Net Income / (Loss) Attributable to Noncontrolling Interest	-	-	-	-	-	-	0.00	-	-	-	0.42
Basic Earnings per Share	$1.12	$1.55	$1.69	$6.82	$1.71	$1.60	$1.60	$1.34	$1.68	$1.54	$0.07
Weighted Average Basic Shares Outstanding	11.97M	11.82M	11.85M	11.81M	11.85M	11.74M	11.79M	11.77M	11.85M	11.79M	11.94M
Diluted Earnings per Share	$1.18	$1.53	$1.69	$6.77	$1.59	$1.58	$1.59	$1.33	$1.64	$1.53	$0.07
Weighted Average Diluted Shares Outstanding	11.97M	11.95M	11.92M	11.90M	11.85M	11.93M	11.86M	11.85M	11.85M	11.90M	12.03M
Weighted Average Basic & Diluted Shares Outstanding	11.97M	11.99M	11.94M	11.90M	11.85M	11.90M	11.87M	11.85M	11.85M	12.08M	11.90M
Cash Dividends to Common per Share	$0.26	$0.26	$0.28	$0.28	$0.28	$0.28	$0.30	$0.30	$0.30	$0.30	$0.32

This table details how cash moves in and out of Standex International's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	6/30/2014	6/30/2015	6/30/2016	6/30/2017	6/30/2018	6/30/2019	6/30/2020	6/30/2021	6/30/2022	6/30/2023	6/30/2024
Net Change in Cash & Equivalents	23	22	26	-33	21	-16	26	18	-32	91	-42
Net Cash From Operating Activities	70	64	80	63	65	73	47	84	78	91	93
Net Cash From Continuing Operating Activities	72	66	81	51	52	73	55	82	78	91	93
Net Income / (Loss) Continuing Operations	50	55	52	39	30	48	41	39	61	139	74
Consolidated Net Income / (Loss)	43	55	52	47	37	68	20	36	61	139	73
Net Income / (Loss) Discontinued Operations	-6.88	-0.50	-0.17	7.41	6.24	20	-21	-2.07	-0.09	-0.16	-0.52
Depreciation Expense	15	17	18	18	25	29	32	33	30	28	28
Non-Cash Adjustments To Reconcile Net Income	12	1.51	14	6.44	3.04	4.02	6.11	22	12	-51	9.69
Changes in Operating Assets and Liabilities, net	-4.24	-7.27	-3.04	-13	-6.46	-8.89	-25	-12	-25	-26	-18
Net Cash From Discontinued Operating Activities	-1.69	-2.13	-0.90	13	13	0.42	-7.44	1.72	-0.42	0.03	-0.69
Net Cash From Investing Activities	-33	-79	-29	-179	-32	-50	-0.62	-39	-31	42	-62
Net Cash From Continuing Investing Activities	-36	-79	-32	-178	-29	-158	-21	-39	-31	42	-62
Purchase of Property, Plant & Equipment	-19	-23	-18	-25	-24	-33	-22	-22	-24	-24	-20
Acquisitions	-23	-57	-14	-154	-10	-128	-0.62	-27	-13	0.00	-49
Sale of Property, Plant & Equipment	0.12	0.07	0.38	1.11	2.85	3.16	0.18	0.12	1.82	1.74	0.00
Divestitures	-	-	-	-	-	0.00	0.00	12	0.00	67	7.77
Other Investing Activities, net	6.17	1.13	-0.42	0.11	1.82	-0.38	1.34	-1.73	4.01	-2.93	-0.27
Net Cash From Discontinued Investing Activities	2.45	0.00	2.80	-0.99	-2.97	108	20	0.00	0.00	0.00	0.00
Net Cash From Financing Activities	-15	45	-21	85	-12	-38	-19	-32	-69	-40	-69
Net Cash From Continuing Financing Activities	-15	45	-21	85	-12	-38	-19	-32	-69	-40	-69
Repayment of Debt	-76	-217	-75	-164	-165	-237	-105	-17	-25	-226	-25
Repurchase of Common Equity	-7.79	-10	-5.64	-7.81	-2.65	-33	-10	-21	-31	-26	-32
Payment of Dividends	-4.79	-5.82	-6.85	-7.85	-8.89	-9.83	-11	-11	-12	-13	-14
Issuance of Debt	71	275	65	264	164	242	107	17	0.00	225	0.00
Issuance of Common Equity	1.10	0.70	0.94	0.85	0.92	1.13	1.74	1.27	1.42	1.34	1.53
Other Financing Activities, net	1.65	2.09	0.80	0.00	0.00	-0.91	-0.87	-0.36	-2.17	-1.17	0.00
Other Net Changes in Cash	-	-	-	-	0.29	-	-1.98	4.80	-	-1.46	-3.33
Cash Interest Paid	1.83	2.55	2.35	3.26	6.18	9.47	6.32	4.90	4.75	4.23	4.09
Cash Income Taxes Paid	14	13	25	20	22	24	19	17	18	26	28

This table details how cash moves in and out of Standex International's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025
Period end date	6/30/2022	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Change in Cash & Equivalents	-29	-1.42	10	62	20	-69	16	-3.63	15	10	-43
Net Cash From Operating Activities	29	-2.70	30	23	40	16	24	24	29	18	9.06
Net Cash From Continuing Operating Activities	30	-2.71	30	23	40	16	24	24	29	18	9.12
Net Income / (Loss) Continuing Operations	13	18	20	81	20	19	19	16	20	18	1.29
Consolidated Net Income / (Loss)	13	18	20	81	20	19	19	16	20	18	1.28
Net Income / (Loss) Discontinued Operations	0.05	-0.05	-0.04	-0.06	-0.02	-0.08	-0.20	-0.14	-0.10	0.01	-0.01
Depreciation Expense	7.29	7.01	6.96	7.31	7.20	7.08	6.89	7.18	6.99	7.06	8.51
Non-Cash Adjustments To Reconcile Net Income	34	1.50	-27	-65	39	2.32	-13	4.25	0.54	-4.32	0.71
Changes in Operating Assets and Liabilities, net	-25	-30	29	-0.05	-26	-12	10	-2.92	1.51	-3.38	-1.39
Net Cash From Discontinued Operating Activities	-0.05	0.00	-0.05	0.01	0.07	-0.23	-0.20	-0.08	-0.19	0.03	-0.06
Net Cash From Investing Activities	-14	-5.22	-5.71	60	-7.49	-33	-4.25	-16	-7.67	-6.31	-423
Net Cash From Continuing Investing Activities	-14	-5.22	-5.71	60	-7.49	-33	-4.25	-16	-7.67	-6.31	-423
Purchase of Property, Plant & Equipment	-11	-5.27	-5.76	-5.62	-7.62	-4.34	-4.25	-5.18	-6.53	-6.73	-6.97
Acquisitions	-3.08	0.00	-	-	-	-29	-	-18	-1.14	0.00	-420
Other Investing Activities, net	-1.71	0.04	0.06	-1.42	-1.61	0.00	-	-0.27	-	0.41	3.49
Net Cash From Financing Activities	-39	12	-20	-22	-10	-50	-7.62	-8.53	-3.37	-6.27	376
Net Cash From Continuing Financing Activities	-39	12	-20	-22	-10	-50	-7.62	-8.53	-3.37	-6.27	376
Repayment of Debt	-25	0.00	-16	-210	-	-25	-	-	-	0.00	-339
Repurchase of Common Equity	-10	-8.39	-5.12	-5.07	-6.95	-22	-4.49	-5.13	-0.04	-4.38	-5.20
Payment of Dividends	-3.10	-3.07	-3.33	-3.30	-3.29	-3.29	-3.55	-3.54	-3.53	-3.53	-3.83
Issuance of Common Equity	0.10	0.84	0.16	0.18	0.17	0.77	0.42	0.14	0.20	1.64	0.16
Other Net Changes in Cash	-	-	-	0.92	-2.51	-	-	-	-	5.40	-5.70
Cash Interest Paid	0.95	1.10	1.13	0.96	1.05	1.28	0.94	0.86	1.01	0.90	2.66
Cash Income Taxes Paid	3.19	9.42	3.40	9.24	4.13	5.12	8.89	5.73	8.23	5.48	0.77

This table presents Standex International's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	6/30/2014	6/30/2015	6/30/2016	6/30/2017	6/30/2018	6/30/2019	6/30/2020	6/30/2021	6/30/2022	6/30/2023	6/30/2024
Total Assets	578	659	690	868	917	922	931	962	934	1,025	1,005
Total Current Assets	300	335	356	361	384	334	332	374	379	483	430
Cash & Equivalents	74	96	122	89	110	93	119	136	105	196	154
Accounts Receivable	108	110	104	127	120	103	98	110	117	123	121
Inventories, net	97	108	105	119	104	76	85	92	105	99	87
Prepaid Expenses	7.03	7.07	4.78	8.40	10	22	19	24	45	34	22
Other Current Assets	-	-	-	-	-	-	-	-	-	31	45
Plant, Property, & Equipment, net	97	109	107	133	137	134	133	133	129	131	135
Total Noncurrent Assets	182	215	228	374	396	454	466	454	427	411	440
Goodwill	126	155	157	243	212	274	271	278	268	265	281
Intangible Assets	31	38	40	103	85	119	106	99	86	76	79
Noncurrent Deferred & Refundable Income Taxes	0.88	0.92	11	1.14	7.45	14	17	9.57	8.19	15	17
Other Noncurrent Operating Assets	23	21	19	27	30	25	71	68	65	56	63
Total Liabilities & Shareholders' Equity	578	659	690	868	917	922	931	962	934	1,025	1,005
Total Liabilities	237	310	320	459	466	458	469	456	435	417	384
Total Current Liabilities	141	139	134	160	161	142	123	144	151	141	128
Accounts Payable	85	81	77	96	79	54	55	75	75	69	63
Accrued Expenses	51	48	51	59	58	50	60	62	68	62	57
Current Deferred & Payable Income Tax Liabilities	4.93	10	4.70	4.78	6.05	5.74	7.43	7.24	8.48	10	7.50
Total Noncurrent Liabilities	96	172	186	299	305	316	346	312	284	277	256
Long-Term Debt	45	102	92	192	194	198	199	199	175	173	149
Other Noncurrent Operating Liabilities	8.54	9.16	10	11	26	0.00	147	113	109	103	107
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Redeemable Noncontrolling Interest	-	-	-	-	-	-	-	-	-	-	0.00
Total Equity & Noncontrolling Interests	341	349	370	409	451	464	462	506	499	607	622
Total Preferred & Common Equity	341	349	370	409	451	464	462	506	499	607	622
Total Common Equity	341	349	370	409	451	464	462	506	499	607	622
Common Stock	85	89	94	99	103	107	115	123	133	143	148
Retained Earnings	584	633	678	717	761	818	828	852	901	1,027	1,086
Treasury Stock	-273	-281	-284	-291	-292	-324	-333	-353	-382	-404	-430
Accumulated Other Comprehensive Income / (Loss)	-56	-93	-118	-116	-122	-137	-148	-116	-153	-158	-183

This table presents Standex International's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025
Period end date	3/31/2022	9/30/2022	12/31/2022	3/31/2023	9/30/2023	12/31/2023	3/31/2024	9/30/2024	12/31/2024
Total Assets	974	921	957	1,015	981	1,005	994	1,038	1,483
Total Current Assets	411	385	401	461	420	436	419	447	465
Cash & Equivalents	134	103	113	175	127	142	139	165	121
Accounts Receivable	115	114	120	121	127	126	121	119	153
Inventories, net	104	110	106	105	98	99	95	90	104
Prepaid Expenses	42	51	49	57	67	66	62	24	31
Other Current Assets	-	-	-	-	-	-	-	50	56
Plant, Property, & Equipment, net	128	125	130	131	129	133	135	138	138
Total Noncurrent Assets	435	412	426	424	432	436	439	452	880
Goodwill	275	261	270	269	275	280	282	292	587
Intangible Assets	92	82	82	80	84	83	82	79	208
Noncurrent Deferred & Refundable Income Taxes	5.37	6.46	7.40	9.21	14	14	15	19	22
Other Noncurrent Operating Assets	63	62	63	65	59	59	60	62	64
Total Liabilities & Shareholders' Equity	974	921	957	1,015	981	1,005	994	1,038	1,483
Total Liabilities	446	430	427	410	387	384	375	380	800
Total Current Liabilities	142	124	132	131	132	131	122	126	138
Accounts Payable	75	66	66	68	62	64	58	67	73
Accrued Expenses	57	53	53	56	60	56	55	53	60
Current Deferred & Payable Income Tax Liabilities	9.28	4.71	9.78	7.37	9.90	11	8.45	6.61	5.18
Total Noncurrent Liabilities	304	305	295	279	255	254	252	254	662
Long-Term Debt	200	199	188	173	149	149	149	149	534
Other Noncurrent Operating Liabilities	104	106	107	106	107	105	103	105	128
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Redeemable Noncontrolling Interest	-	-	-	-	-	-	-	-	27
Total Equity & Noncontrolling Interests	528	492	529	606	595	621	619	658	656
Total Preferred & Common Equity	528	492	529	606	595	621	619	658	656
Total Common Equity	528	492	529	606	595	621	619	658	656
Common Stock	130	133	135	139	141	143	147	150	174
Retained Earnings	891	917	933	1,010	1,043	1,058	1,070	1,101	1,098
Treasury Stock	-372	-387	-392	-397	-421	-425	-430	-432	-428
Accumulated Other Comprehensive Income / (Loss)	-122	-171	-147	-147	-168	-156	-168	-161	-188

This table displays calculated financial ratios and metrics derived from Standex International's official financial filings.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	6/30/2014	6/30/2015	6/30/2016	6/30/2017	6/30/2018	6/30/2019	6/30/2020	6/30/2021	6/30/2022	6/30/2023	6/30/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	6.35%	7.81%	-2.66%	-13.80%	-8.08%	7.46%	-5.53%	8.55%	12.05%	0.78%	-2.75%
EBITDA Growth	9.92%	13.37%	-6.89%	-18.51%	39.34%	5.49%	-12.31%	-2.04%	27.11%	69.29%	-35.39%
EBIT Growth	13.41%	13.17%	-9.94%	-22.96%	38.94%	1.72%	-20.82%	-4.64%	48.51%	94.30%	-41.15%
NOPAT Growth	5.10%	18.10%	-6.06%	-18.47%	-20.63%	65.15%	-19.88%	-5.75%	54.33%	117.45%	-45.80%
Net Income Growth	-4.42%	27.71%	-4.91%	-10.59%	-21.36%	85.54%	-70.27%	80.67%	68.32%	126.40%	-47.43%
EPS Growth	-4.56%	27.46%	-4.45%	-10.54%	-21.64%	88.11%	-69.70%	82.21%	70.37%	128.85%	-46.98%
Operating Cash Flow Growth	16.81%	-8.90%	25.43%	-21.02%	2.34%	12.97%	-35.59%	76.92%	-7.02%	16.84%	2.04%
Free Cash Flow Firm Growth	484.73%	-19.48%	375.99%	-288.31%	171.97%	-134.13%	254.90%	-72.78%	401.11%	93.07%	-63.11%
Invested Capital Growth	10.83%	13.70%	-4.22%	50.94%	-11.37%	19.61%	-0.59%	5.54%	-0.04%	2.78%	5.30%
Revenue Q/Q Growth	6.22%	0.32%	-0.79%	-11.48%	-12.00%	64.22%	-18.74%	5.99%	1.14%	0.49%	-1.12%
EBITDA Q/Q Growth	3.86%	5.38%	-8.73%	-7.15%	11.96%	-3.00%	-8.56%	15.34%	-4.45%	5.10%	-1.36%
EBIT Q/Q Growth	4.78%	5.84%	-11.30%	-8.27%	14.07%	-6.71%	-12.86%	25.22%	-4.73%	6.07%	-1.54%
NOPAT Q/Q Growth	4.28%	5.37%	-8.01%	-4.64%	7.37%	5.94%	-14.11%	26.08%	-1.84%	4.60%	-0.29%
Net Income Q/Q Growth	-5.40%	13.08%	-7.45%	4.38%	-4.01%	-0.33%	-34.34%	49.74%	-1.10%	5.22%	-0.78%
EPS Q/Q Growth	-5.63%	13.26%	-7.27%	4.29%	-4.03%	0.19%	-34.27%	0.00%	0.00%	3.67%	0.82%
Operating Cash Flow Q/Q Growth	-9.41%	10.98%	-10.08%	-2.09%	6.19%	18.72%	-35.90%	14.69%	-3.18%	13.81%	-11.41%
Free Cash Flow Firm Q/Q Growth	-83.41%	167.49%	-9.21%	-36.08%	1,457.27%	-183.69%	-27.96%	-48.27%	70.49%	0.52%	-10.95%
Invested Capital Q/Q Growth	-1.62%	-9.68%	-9.52%	-0.69%	-18.20%	-4.93%	-2.99%	0.85%	-4.07%	-3.05%	-2.03%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	33.27%	32.05%	33.56%	33.27%	37.95%	36.67%	35.64%	36.76%	36.71%	38.47%	39.13%
EBITDA Margin	11.82%	12.43%	11.89%	11.24%	17.04%	16.72%	15.52%	14.01%	15.89%	26.70%	17.74%
Operating Margin	9.20%	10.19%	9.36%	8.79%	13.12%	12.42%	10.01%	9.02%	12.01%	23.09%	14.12%
EBIT Margin	9.78%	10.27%	9.50%	8.49%	12.83%	12.15%	10.18%	8.94%	11.85%	22.85%	13.83%
Profit (Net Income) Margin	5.99%	7.09%	6.93%	7.18%	6.15%	10.61%	3.34%	5.56%	8.35%	18.76%	10.14%
Tax Burden Percent	63.22%	71.92%	75.97%	91.34%	53.52%	101.40%	37.33%	69.21%	75.52%	84.78%	76.82%
Interest Burden Percent	96.79%	96.01%	95.98%	92.65%	89.49%	86.16%	87.86%	89.79%	93.26%	96.81%	95.44%
Effective Tax Rate	26.63%	27.42%	23.78%	23.20%	55.60%	27.90%	24.15%	26.86%	24.37%	15.12%	22.64%
Return on Invested Capital (ROIC)	16.31%	17.15%	15.46%	10.27%	7.18%	11.50%	8.48%	7.80%	11.73%	25.16%	13.10%
ROIC Less NNEP Spread (ROIC-NNEP)	44.25%	36.94%	27.91%	18.06%	10.77%	37.51%	-24.37%	-1.83%	3.63%	-0.92%	53.95%
Return on Net Nonoperating Assets (RNNOA)	-2.74%	-1.26%	-0.97%	1.69%	1.33%	3.35%	-4.12%	-0.27%	0.48%	-0.04%	-1.21%
Return on Equity (ROE)	13.57%	15.88%	14.49%	11.96%	8.52%	14.84%	4.36%	7.54%	12.21%	25.12%	11.89%
Cash Return on Invested Capital (CROIC)	6.04%	4.33%	19.77%	-30.33%	19.24%	-6.36%	9.08%	2.41%	11.77%	22.41%	7.94%
Operating Return on Assets (OROA)	12.87%	12.82%	10.58%	7.06%	8.56%	8.45%	6.64%	6.20%	9.19%	17.29%	9.82%
Return on Assets (ROA)	7.87%	8.85%	7.71%	5.97%	4.10%	7.39%	2.18%	3.85%	6.47%	14.19%	7.20%
Return on Common Equity (ROCE)	13.57%	15.88%	14.49%	11.96%	8.52%	14.84%	4.36%	7.54%	12.21%	25.12%	11.89%
Return on Equity Simple (ROE_SIMPLE)	12.58%	15.71%	14.07%	11.39%	8.12%	14.63%	4.37%	7.20%	12.29%	22.88%	11.76%
Net Operating Profit after Tax (NOPAT)	48	57	54	44	35	57	46	43	67	145	79
NOPAT Margin	6.75%	7.39%	7.13%	6.75%	5.83%	8.95%	7.59%	6.59%	9.08%	19.60%	10.92%
Net Nonoperating Expense Percent (NNEP)	-27.94%	-19.80%	-12.44%	-7.79%	-3.59%	-26.01%	32.86%	9.63%	8.09%	26.07%	-40.84%
Cost of Revenue to Revenue	66.73%	67.95%	66.44%	66.73%	62.05%	63.33%	64.36%	63.24%	63.29%	61.53%	60.87%
SG&A Expenses to Revenue	23.15%	21.48%	22.65%	22.39%	23.62%	23.49%	24.56%	24.85%	23.10%	23.26%	23.53%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	24.07%	21.87%	24.20%	24.48%	24.83%	24.25%	25.63%	27.75%	24.70%	15.38%	25.01%
Earnings before Interest and Taxes (EBIT)	70	79	71	55	76	78	62	59	87	169	100
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	85	96	89	73	101	107	94	92	117	198	128
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	2.65	2.64	2.73	1.89	1.49	2.24	2.01	2.75	3.07
Price to Tangible Book Value (P/TBV)	0.00	0.00	5.69	16.97	7.99	12.21	8.17	8.75	6.91	6.26	7.29
Price to Revenue (P/Rev)	0.00	0.00	1.30	1.66	2.07	1.37	1.14	1.73	1.37	2.26	2.65
Price to Earnings (P/E)	0.00	0.00	18.81	23.14	33.62	12.91	33.99	31.05	16.38	12.03	26.09
Dividend Yield	0.56%	0.63%	0.71%	0.73%	0.73%	1.13%	1.56%	1.02%	1.22%	0.78%	0.55%
Earnings Yield	0.00%	0.00%	5.32%	4.32%	2.97%	7.74%	2.94%	3.22%	6.10%	8.31%	3.83%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	2.80	2.31	2.90	1.81	1.42	2.10	1.89	2.82	3.09
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	1.26	1.82	2.21	1.53	1.27	1.82	1.46	2.23	2.64
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	10.62	16.21	12.96	9.17	8.17	13.01	9.21	8.34	14.88
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	13.29	21.46	17.21	12.62	12.45	20.37	12.34	9.74	19.08
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	17.70	27.00	37.90	17.13	16.70	27.63	16.11	11.36	24.16
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	11.82	18.61	20.25	13.38	16.23	14.30	13.84	18.17	20.52
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	13.84	0.00	14.15	0.00	15.60	89.42	16.06	12.75	39.85
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.13	0.29	0.25	0.47	0.43	0.43	0.43	0.39	0.35	0.29	0.24
Long-Term Debt to Equity	0.13	0.29	0.25	0.47	0.43	0.43	0.43	0.39	0.35	0.29	0.24
Financial Leverage	-0.06	-0.03	-0.03	0.09	0.12	0.09	0.17	0.15	0.13	0.04	-0.02
Leverage Ratio	1.72	1.79	1.88	2.00	2.08	2.01	2.00	1.96	1.89	1.77	1.65
Compound Leverage Factor	1.67	1.72	1.80	1.85	1.86	1.73	1.76	1.76	1.76	1.71	1.58
Debt to Total Capital	11.68%	22.60%	19.93%	31.96%	30.06%	29.85%	30.14%	28.26%	25.93%	22.21%	19.33%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	11.68%	22.60%	19.93%	31.96%	30.06%	29.85%	30.14%	28.26%	25.93%	22.21%	19.33%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	88.32%	77.40%	80.07%	68.04%	69.94%	70.15%	69.86%	71.74%	74.07%	77.79%	80.68%
Debt to EBITDA	0.53	1.06	1.03	2.64	1.91	1.85	2.12	2.17	1.50	0.88	1.16
Net Debt to EBITDA	-0.35	0.06	-0.33	1.42	0.83	0.98	0.86	0.69	0.60	-0.11	-0.04
Long-Term Debt to EBITDA	0.53	1.06	1.03	2.64	1.91	1.85	2.12	2.17	1.50	0.88	1.16
Debt to NOPAT	0.93	1.78	1.72	4.39	5.58	3.45	4.34	4.61	2.62	1.19	1.89
Net Debt to NOPAT	-0.60	0.10	-0.56	2.37	2.43	1.82	1.75	1.46	1.05	-0.15	-0.07
Long-Term Debt to NOPAT	0.93	1.78	1.72	4.39	5.58	3.45	4.34	4.61	2.62	1.19	1.89
Altman Z-Score	0.00	0.00	5.02	3.80	3.96	3.62	3.26	3.90	4.13	5.47	5.90
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.12	2.42	2.65	2.26	2.38	2.36	2.70	2.61	2.51	3.43	3.37
Quick Ratio	1.29	1.49	1.68	1.35	1.42	1.39	1.77	1.71	1.47	2.26	2.16
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	18	14	69	-129	93	-32	49	13	67	129	48
Operating Cash Flow to CapEx	375.65%	284.68%	459.84%	260.52%	313.42%	249.96%	221.37%	386.33%	352.12%	403.06%	456.48%
Free Cash Flow to Firm to Interest Expense	7.95	4.56	23.88	-31.93	11.57	-2.95	6.57	2.23	11.41	23.93	10.50
Operating Cash Flow to Interest Expense	31.26	20.26	27.98	15.69	8.09	6.82	6.32	13.95	13.23	16.80	20.39
Operating Cash Flow Less CapEx to Interest Expense	22.94	13.14	21.89	9.67	5.51	4.09	3.47	10.34	9.47	12.63	15.92
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.32	1.25	1.11	0.83	0.67	0.70	0.65	0.69	0.78	0.76	0.71
Accounts Receivable Turnover	6.96	7.08	7.01	5.61	4.83	5.74	6.00	6.31	6.48	6.16	5.89
Inventory Turnover	5.34	5.11	4.67	3.85	3.30	4.49	4.82	4.69	4.72	4.47	4.73
Fixed Asset Turnover	7.57	7.52	6.98	5.40	4.41	4.72	4.53	4.94	5.61	5.71	5.42
Accounts Payable Turnover	6.26	6.32	6.33	4.98	4.21	6.09	7.13	6.40	6.24	6.37	6.65
Days Sales Outstanding (DSO)	52.41	51.56	52.07	65.08	75.65	63.64	60.84	57.86	56.33	59.23	62.00
Days Inventory Outstanding (DIO)	68.31	71.44	78.11	94.90	110.48	81.33	75.67	77.80	77.33	81.60	77.24
Days Payable Outstanding (DPO)	58.33	57.73	57.70	73.28	86.65	59.96	51.18	57.03	58.54	57.29	54.91
Cash Conversion Cycle (CCC)	62.38	65.27	72.48	86.70	99.49	85.01	85.33	78.63	75.12	83.55	84.33
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	312	354	339	512	454	543	540	570	569	585	616
Invested Capital Turnover	2.42	2.32	2.17	1.52	1.23	1.28	1.12	1.18	1.29	1.28	1.20
Increase / (Decrease) in Invested Capital	30	43	-15	173	-58	89	-3.22	30	-0.22	16	31
Enterprise Value (EV)	0.00	0.00	949	1,180	1,315	981	767	1,196	1,076	1,650	1,901
Market Capitalization	0.00	0.00	979	1,077	1,231	877	686	1,132	1,006	1,672	1,907
Book Value per Share	$27.01	$27.54	$28.89	$32.06	$35.13	$36.70	$37.20	$41.30	$41.37	$51.03	$52.43
Tangible Book Value per Share	$14.53	$12.31	$13.45	$4.98	$12.01	$5.68	$6.77	$10.56	$12.07	$22.43	$22.07
Total Capital	386	450	462	601	645	662	661	706	674	781	770
Total Debt	45	102	92	192	194	198	199	199	175	173	149
Total Long-Term Debt	45	102	92	192	194	198	199	199	175	173	149
Net Debt	-29	5.63	-30	103	84	104	80	63	70	-22	-5.33
Capital Expenditures (CapEx)	19	22	17	24	21	29	21	22	22	23	20
Debt-free, Cash-free Net Working Capital (DFCFNWC)	85	100	100	112	113	99	90	94	123	147	148
Debt-free Net Working Capital (DFNWC)	159	197	222	201	223	192	209	231	228	342	303
Net Working Capital (NWC)	159	197	222	201	223	192	209	231	228	342	303
Net Nonoperating Expense (NNE)	5.46	2.33	1.56	-2.83	-1.91	-11	26	6.80	5.39	6.22	5.63
Net Nonoperating Obligations (NNO)	-29	5.63	-31	103	3.06	79	78	63	70	-22	-5.33
Total Depreciation and Amortization (D&A)	15	17	18	18	25	29	32	33	30	28	28
Debt-free, Cash-free Net Working Capital to Revenue	11.80%	13.01%	13.27%	17.34%	18.98%	15.49%	14.94%	14.37%	16.78%	19.78%	20.58%
Debt-free Net Working Capital to Revenue	22.17%	25.46%	29.50%	31.01%	37.38%	30.04%	34.59%	35.15%	31.04%	46.19%	41.98%
Net Working Capital to Revenue	22.17%	25.46%	29.50%	31.01%	37.38%	30.04%	34.59%	35.15%	31.04%	46.19%	41.98%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$3.39	$4.33	$4.11	$3.68	$2.88	$5.40	$1.64	$3.00	$5.13	$11.77	$6.22
Adjusted Weighted Average Basic Shares Outstanding	12.76M	12.77M	12.78M	12.78M	12.83M	12.45M	12.38M	12.21M	11.97M	11.85M	11.85M
Adjusted Diluted Earnings per Share	$3.35	$4.27	$4.08	$3.65	$2.86	$5.38	$1.63	$2.97	$5.06	$11.58	$6.14
Adjusted Weighted Average Diluted Shares Outstanding	12.76M	12.77M	12.78M	12.78M	12.83M	12.45M	12.38M	12.21M	11.97M	11.85M	11.85M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	12.76M	12.77M	12.78M	12.78M	12.83M	12.45M	12.38M	12.21M	11.97M	11.85M	11.85M
Normalized Net Operating Profit after Tax (NOPAT)	56	60	57	54	60	60	51	57	71	96	87
Normalized NOPAT Margin	7.78%	7.72%	7.56%	8.36%	10.03%	9.45%	8.40%	8.72%	9.70%	12.99%	12.06%
Pre Tax Income Margin	9.47%	9.86%	9.12%	7.87%	11.48%	10.47%	8.94%	8.03%	11.05%	22.12%	13.20%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	31.15	25.08	24.87	13.60	9.52	7.22	8.23	9.80	14.84	31.33	21.93
NOPAT to Interest Expense	21.49	18.06	18.68	10.81	4.32	5.33	6.14	7.22	11.37	26.87	17.32
EBIT Less CapEx to Interest Expense	22.83	17.96	18.78	7.58	6.94	4.50	5.38	6.18	11.08	27.16	17.47
NOPAT Less CapEx to Interest Expense	13.17	10.94	12.59	4.79	1.74	2.60	3.29	3.61	7.61	22.70	12.85
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	11.18%	10.63%	13.15%	16.87%	24.28%	14.47%	52.54%	31.39%	19.95%	9.34%	19.02%
Augmented Payout Ratio	29.35%	29.55%	23.98%	33.64%	31.53%	63.64%	104.24%	89.52%	71.14%	27.71%	62.57%

This table displays calculated financial ratios and metrics derived from Standex International's official financial filings.

Metric	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025
Period end date	6/30/2022	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	4.70%	2.84%	1.12%	-2.61%	1.94%	2.31%	-5.00%	-3.83%	-4.32%	-7.74%	6.40%
EBITDA Growth	-15.55%	5.73%	20.19%	203.58%	36.91%	2.70%	-7.02%	-70.14%	-4.94%	-5.93%	-50.36%
EBIT Growth	-16.41%	10.82%	29.75%	263.74%	51.72%	3.16%	-8.52%	-75.83%	-5.47%	-7.46%	-70.30%
NOPAT Growth	-7.82%	16.72%	29.46%	343.81%	44.28%	2.58%	-5.19%	-79.20%	-1.14%	-7.68%	-72.89%
Net Income Growth	-4.87%	15.50%	33.76%	364.78%	52.00%	2.98%	-5.85%	-80.38%	-2.87%	-3.28%	-93.24%
EPS Growth	0.00%	17.69%	36.29%	405.22%	34.75%	3.27%	-5.92%	-80.35%	3.14%	-3.16%	-95.60%
Operating Cash Flow Growth	-7.98%	-120.68%	27.85%	95.32%	37.40%	698.59%	-20.77%	4.68%	-29.49%	8.61%	-61.56%
Free Cash Flow Firm Growth	206.11%	-21.82%	-84.51%	815.53%	-64.49%	-160.07%	-407.48%	-111.28%	-291.31%	17.80%	-3,192.43%
Invested Capital Growth	-0.04%	0.96%	2.89%	1.71%	2.78%	4.97%	5.77%	4.20%	5.30%	4.23%	74.83%
Revenue Q/Q Growth	-2.40%	-2.24%	3.98%	-1.84%	2.17%	-1.89%	-3.45%	-0.64%	1.65%	-5.40%	11.35%
EBITDA Q/Q Growth	-16.89%	24.02%	7.91%	172.95%	-62.52%	-6.97%	-2.31%	-12.34%	19.31%	-7.93%	-48.45%
EBIT Q/Q Growth	-22.32%	34.83%	10.30%	214.86%	-67.60%	-8.32%	-2.19%	-16.80%	26.71%	-10.25%	-68.61%
NOPAT Q/Q Growth	-21.28%	36.49%	6.17%	289.07%	-74.41%	-2.96%	-1.87%	-14.64%	21.62%	-9.38%	-71.19%
Net Income Q/Q Growth	-23.40%	37.69%	9.70%	301.69%	-74.95%	-6.72%	0.30%	-16.28%	24.01%	-7.12%	-92.99%
EPS Q/Q Growth	-11.94%	29.66%	10.46%	300.59%	-76.51%	-0.63%	0.63%	-16.35%	23.31%	-6.71%	-95.42%
Operating Cash Flow Q/Q Growth	147.21%	-109.17%	1,200.37%	-21.74%	73.91%	-60.03%	45.64%	3.40%	17.14%	-38.44%	-48.46%
Free Cash Flow Firm Q/Q Growth	246.83%	-2.89%	-68.28%	1,482.19%	-92.71%	-264.30%	-62.33%	41.95%	-23.55%	29.40%	-6,402.04%
Invested Capital Q/Q Growth	-4.07%	3.13%	0.92%	1.86%	-3.05%	5.33%	1.70%	0.34%	-2.03%	4.26%	70.58%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	36.03%	37.79%	38.51%	38.46%	39.09%	39.31%	40.17%	38.52%	38.52%	41.11%	37.64%
EBITDA Margin	14.09%	17.87%	18.55%	51.58%	18.92%	17.94%	18.15%	16.02%	18.80%	18.30%	8.47%
Operating Margin	10.41%	14.56%	14.81%	48.02%	15.12%	14.57%	14.48%	12.32%	15.07%	14.14%	4.46%
EBIT Margin	10.15%	13.99%	14.84%	47.62%	15.10%	14.11%	14.29%	11.97%	14.92%	14.15%	3.99%
Profit (Net Income) Margin	7.18%	10.12%	10.67%	43.68%	10.71%	10.18%	10.58%	8.91%	10.87%	10.68%	0.67%
Tax Burden Percent	76.47%	75.86%	76.18%	93.23%	74.15%	75.88%	77.08%	77.95%	76.58%	78.60%	63.81%
Interest Burden Percent	92.58%	95.30%	94.38%	98.39%	95.65%	95.11%	96.00%	95.53%	95.16%	95.95%	26.38%
Effective Tax Rate	23.80%	23.95%	23.66%	6.70%	25.78%	23.81%	22.09%	21.35%	23.04%	21.43%	35.54%
Return on Invested Capital (ROIC)	10.24%	14.02%	14.36%	55.20%	14.41%	13.75%	13.61%	11.46%	13.91%	12.46%	2.40%
ROIC Less NNEP Spread (ROIC-NNEP)	8.17%	11.93%	12.32%	48.71%	10.36%	10.85%	10.00%	-22.98%	23.35%	-11.60%	0.40%
Return on Net Nonoperating Assets (RNNOA)	1.08%	1.95%	1.35%	2.75%	0.45%	1.17%	0.60%	-0.15%	-0.52%	-0.06%	0.13%
Return on Equity (ROE)	11.32%	15.98%	15.72%	57.95%	14.85%	14.92%	14.22%	11.31%	13.39%	12.41%	2.52%
Cash Return on Invested Capital (CROIC)	11.77%	10.97%	9.90%	21.50%	22.41%	19.37%	18.11%	8.69%	7.94%	8.11%	-47.10%
Operating Return on Assets (OROA)	7.87%	11.01%	11.44%	35.31%	11.42%	11.05%	10.72%	8.68%	10.59%	9.90%	2.30%
Return on Assets (ROA)	5.57%	7.96%	8.22%	32.39%	8.10%	7.98%	7.94%	6.47%	7.72%	7.47%	0.39%
Return on Common Equity (ROCE)	11.32%	15.98%	15.72%	57.95%	14.85%	14.92%	14.22%	11.31%	13.39%	12.41%	2.47%
Return on Equity Simple (ROE_SIMPLE)	0.00%	12.98%	13.02%	21.81%	0.00%	23.47%	22.30%	11.90%	0.00%	11.01%	8.36%
Net Operating Profit after Tax (NOPAT)	15	20	21	83	21	21	20	17	21	19	5.46
NOPAT Margin	7.93%	11.07%	11.30%	44.80%	11.22%	11.10%	11.28%	9.69%	11.59%	11.11%	2.87%
Net Nonoperating Expense Percent (NNEP)	2.07%	2.10%	2.05%	6.49%	4.04%	2.89%	3.61%	34.44%	-9.44%	24.07%	1.99%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	2.62%	-	-	-	0.46%
Cost of Revenue to Revenue	63.97%	62.21%	61.49%	61.54%	60.91%	60.69%	59.83%	61.48%	61.48%	58.89%	62.36%
SG&A Expenses to Revenue	22.36%	22.75%	23.28%	23.30%	23.67%	23.59%	24.26%	23.56%	22.74%	25.25%	24.06%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	25.62%	23.24%	23.70%	-9.56%	23.97%	24.74%	25.69%	26.20%	23.46%	26.97%	33.18%
Earnings before Interest and Taxes (EBIT)	19	25	28	88	28	26	26	21	27	24	7.57
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	26	32	35	95	36	33	32	28	34	31	16
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.01	1.96	2.29	2.39	2.75	2.89	3.02	3.48	3.07	3.29	3.44
Price to Tangible Book Value (P/TBV)	6.91	6.47	6.83	5.65	6.26	7.28	7.27	8.45	7.29	7.55	0.00
Price to Revenue (P/Rev)	1.37	1.30	1.63	1.96	2.26	2.30	2.54	2.96	2.65	3.07	3.15
Price to Earnings (P/E)	16.38	15.08	17.61	10.97	12.03	12.30	13.53	29.27	26.09	29.90	41.50
Dividend Yield	1.22%	1.29%	1.05%	0.89%	0.78%	0.77%	0.71%	0.47%	0.55%	0.49%	0.65%
Earnings Yield	6.10%	6.63%	5.68%	9.12%	8.31%	8.13%	7.39%	3.42%	3.83%	3.34%	2.41%
Enterprise Value to Invested Capital (EV/IC)	1.89	1.80	2.17	2.40	2.82	2.82	3.00	3.44	3.09	3.35	2.46
Enterprise Value to Revenue (EV/Rev)	1.46	1.43	1.73	1.96	2.23	2.33	2.55	2.97	2.64	3.05	3.76
Enterprise Value to EBITDA (EV/EBITDA)	9.21	8.92	10.34	7.69	8.34	8.75	9.57	16.71	14.88	17.09	24.64
Enterprise Value to EBIT (EV/EBIT)	12.34	11.81	13.41	9.06	9.74	10.22	11.19	21.39	19.08	22.01	33.82
Enterprise Value to NOPAT (EV/NOPAT)	16.11	15.20	17.28	10.42	11.36	11.93	12.99	27.43	24.16	27.89	42.64
Enterprise Value to Operating Cash Flow (EV/OCF)	13.84	17.09	18.81	18.14	18.17	15.85	18.14	20.70	20.52	22.87	33.93
Enterprise Value to Free Cash Flow (EV/FCFF)	16.06	16.52	22.26	11.24	12.75	14.92	17.01	40.41	39.85	42.12	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.35	0.40	0.35	0.29	0.29	0.25	0.24	0.24	0.24	0.23	0.78
Long-Term Debt to Equity	0.35	0.40	0.35	0.29	0.29	0.25	0.24	0.24	0.24	0.23	0.78
Financial Leverage	0.13	0.16	0.11	0.06	0.04	0.11	0.06	0.01	-0.02	0.00	0.32
Leverage Ratio	1.89	1.87	1.83	1.75	1.77	1.75	1.71	1.64	1.65	1.61	1.91
Compound Leverage Factor	1.75	1.79	1.73	1.73	1.69	1.67	1.64	1.57	1.57	1.55	0.50
Debt to Total Capital	25.93%	28.80%	26.15%	22.25%	22.21%	19.99%	19.33%	19.38%	19.33%	18.46%	43.90%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	25.93%	28.80%	26.15%	22.25%	22.21%	19.99%	19.33%	19.38%	19.33%	18.46%	43.90%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	2.19%
Common Equity to Total Capital	74.07%	71.20%	73.85%	77.75%	77.79%	80.01%	80.67%	80.62%	80.68%	81.54%	53.91%
Debt to EBITDA	1.50	1.68	1.51	0.92	0.88	0.75	0.76	1.15	1.16	1.18	4.88
Net Debt to EBITDA	0.60	0.81	0.59	-0.01	-0.11	0.11	0.03	0.08	-0.04	-0.12	3.77
Long-Term Debt to EBITDA	1.50	1.68	1.51	0.92	0.88	0.75	0.76	1.15	1.16	1.18	4.88
Debt to NOPAT	2.62	2.86	2.52	1.25	1.19	1.02	1.03	1.88	1.89	1.93	8.44
Net Debt to NOPAT	1.05	1.37	0.99	-0.01	-0.15	0.15	0.04	0.13	-0.07	-0.20	6.53
Long-Term Debt to NOPAT	2.62	2.86	2.52	1.25	1.19	1.02	1.03	1.88	1.89	1.93	8.44
Altman Z-Score	3.88	3.97	4.28	4.92	5.02	5.35	5.57	6.12	5.66	6.04	3.50
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	2.04%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.51	3.09	3.03	3.53	3.43	3.19	3.34	3.43	3.37	3.55	3.37
Quick Ratio	1.47	1.74	1.76	2.27	2.26	1.93	2.05	2.12	2.16	2.25	1.99
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	15	14	4.58	72	5.28	-8.67	-14	-8.17	-10	-7.13	-464
Operating Cash Flow to CapEx	274.00%	-51.32%	516.28%	414.20%	531.13%	372.98%	554.60%	470.59%	436.92%	261.31%	130.05%
Free Cash Flow to Firm to Interest Expense	10.70	12.16	2.92	51.20	4.27	-6.80	-13.82	-8.61	-7.77	-7.30	-83.15
Operating Cash Flow to Interest Expense	21.20	-2.28	18.99	16.45	32.73	12.68	23.13	25.68	21.96	17.99	1.62
Operating Cash Flow Less CapEx to Interest Expense	13.46	-6.71	15.31	12.48	26.57	9.28	18.96	20.22	16.93	11.10	0.38
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.78	0.79	0.77	0.74	0.76	0.78	0.75	0.73	0.71	0.70	0.58
Accounts Receivable Turnover	6.48	6.76	6.54	6.23	6.16	6.19	6.00	6.03	5.89	5.75	5.15
Inventory Turnover	4.72	4.47	4.49	4.41	4.47	4.38	4.38	4.43	4.73	4.53	4.33
Fixed Asset Turnover	5.61	5.77	5.73	5.70	5.71	5.87	5.61	5.49	5.42	5.28	5.31
Accounts Payable Turnover	6.24	6.43	6.60	6.44	6.37	7.10	6.87	7.03	6.65	6.64	6.39
Days Sales Outstanding (DSO)	56.33	53.98	55.80	58.55	59.23	58.95	60.88	60.52	62.00	63.53	70.88
Days Inventory Outstanding (DIO)	77.33	81.72	81.27	82.80	81.60	83.26	83.40	82.35	77.24	80.55	84.31
Days Payable Outstanding (DPO)	58.54	56.80	55.34	56.72	57.29	51.40	53.16	51.94	54.91	54.97	57.13
Cash Conversion Cycle (CCC)	75.12	78.90	81.74	84.63	83.55	90.81	91.13	90.92	84.33	89.11	98.05
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	569	587	593	604	585	616	627	629	616	642	1,096
Invested Capital Turnover	1.29	1.27	1.27	1.23	1.28	1.24	1.21	1.18	1.20	1.12	0.83
Increase / (Decrease) in Invested Capital	-0.22	5.56	17	10	16	29	34	25	31	26	469
Enterprise Value (EV)	1,076	1,058	1,287	1,447	1,650	1,739	1,878	2,165	1,901	2,151	2,699
Market Capitalization	1,006	963	1,213	1,449	1,672	1,717	1,872	2,155	1,907	2,167	2,259
Book Value per Share	$41.37	$41.09	$44.17	$50.70	$51.03	$50.19	$52.15	$52.14	$52.43	$55.51	$54.30
Tangible Book Value per Share	$12.07	$12.44	$14.83	$21.48	$22.43	$19.89	$21.64	$21.49	$22.07	$24.20	($11.44)
Total Capital	674	691	717	779	781	743	769	768	770	807	1,217
Total Debt	175	199	188	173	173	149	149	149	149	149	534
Total Long-Term Debt	175	199	188	173	173	149	149	149	149	149	534
Net Debt	70	95	74	-1.95	-22	22	6.24	9.97	-5.33	-16	413
Capital Expenditures (CapEx)	11	5.27	5.76	5.62	7.62	4.34	4.25	5.18	6.53	6.73	6.97
Debt-free, Cash-free Net Working Capital (DFCFNWC)	123	157	155	155	147	162	163	158	148	157	206
Debt-free Net Working Capital (DFNWC)	228	260	269	330	342	288	305	297	303	321	327
Net Working Capital (NWC)	228	260	269	330	342	288	305	297	303	321	327
Net Nonoperating Expense (NNE)	1.38	1.72	1.18	2.07	0.96	1.69	1.25	1.38	1.30	0.74	4.18
Net Nonoperating Obligations (NNO)	70	95	63	-1.95	-22	22	6.24	9.97	-5.33	-16	413
Total Depreciation and Amortization (D&A)	7.29	7.01	6.96	7.31	7.20	7.08	6.89	7.18	6.99	7.06	8.51
Debt-free, Cash-free Net Working Capital to Revenue	16.78%	21.21%	20.88%	21.01%	19.78%	21.68%	22.16%	21.68%	20.58%	22.17%	28.65%
Debt-free Net Working Capital to Revenue	31.04%	35.18%	36.17%	44.77%	46.19%	38.70%	41.51%	40.73%	41.98%	45.47%	45.53%
Net Working Capital to Revenue	31.04%	35.18%	36.17%	44.77%	46.19%	38.70%	41.51%	40.73%	41.98%	45.47%	45.53%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.12	$1.55	$1.69	$6.82	$1.71	$1.60	$1.60	$1.34	$1.68	$1.54	$0.07
Adjusted Weighted Average Basic Shares Outstanding	11.97M	11.82M	11.85M	11.81M	11.85M	11.74M	11.79M	11.77M	11.85M	11.79M	11.94M
Adjusted Diluted Earnings per Share	$1.18	$1.53	$1.69	$6.77	$1.59	$1.58	$1.59	$1.33	$1.64	$1.53	$0.07
Adjusted Weighted Average Diluted Shares Outstanding	11.97M	11.95M	11.92M	11.90M	11.85M	11.93M	11.86M	11.85M	11.85M	11.90M	12.03M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	11.97M	11.99M	11.94M	11.90M	11.85M	11.90M	11.87M	11.85M	11.85M	12.08M	11.90M
Normalized Net Operating Profit after Tax (NOPAT)	16	21	22	27	22	22	22	21	22	21	17
Normalized NOPAT Margin	8.75%	11.44%	11.58%	14.51%	11.45%	12.09%	12.40%	11.72%	12.15%	12.46%	8.76%
Pre Tax Income Margin	9.39%	13.34%	14.01%	46.85%	14.44%	13.42%	13.72%	11.43%	14.20%	13.58%	1.05%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	13.48	21.29	17.80	62.03	22.99	20.43	25.02	22.36	20.68	24.70	1.36
NOPAT to Interest Expense	10.54	16.84	13.55	58.36	17.08	16.07	19.75	18.10	16.07	19.38	0.98
EBIT Less CapEx to Interest Expense	5.75	16.85	14.12	58.06	16.83	17.03	20.85	16.90	15.65	17.81	0.11
NOPAT Less CapEx to Interest Expense	2.80	12.41	9.88	54.39	10.92	12.67	15.58	12.65	11.05	12.50	-0.27
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	19.95%	19.47%	18.33%	9.69%	9.34%	9.46%	9.70%	18.55%	19.02%	19.52%	26.29%
Augmented Payout Ratio	71.14%	66.96%	69.70%	31.33%	27.71%	37.62%	37.64%	71.13%	62.57%	38.91%	53.19%

Frequently Asked Questions About Standex International's Financials

When does Standex International's financial year end?

According to the most recent income statement we have on file, Standex International's fiscal year ends in June. Their fiscal year 2024 ended on June 30, 2024.

How has Standex International's net income changed over the last 10 years?

Standex International's net income appears to be on an upward trend, with a most recent value of $73.07 million in 2024, rising from $42.87 million in 2014. The previous period was $138.99 million in 2023. See where experts think Standex International is headed by visiting Standex International's forecast page.

What is Standex International's operating income?

Standex International's total operating income in 2024 was $101.74 million, based on the following breakdown:

Total Gross Profit: $282.00 million
Total Operating Expenses: $180.26 million

How has Standex International revenue changed over the last 10 years?

Over the last 10 years, Standex International's total revenue changed from $716.18 million in 2014 to $720.64 million in 2024, a change of 0.6%.

How much debt does Standex International have?

Standex International's total liabilities were at $383.55 million at the end of 2024, a 8.1% decrease from 2023, and a 61.5% increase since 2014.

How much cash does Standex International have?

In the past 10 years, Standex International's cash and equivalents has ranged from $74.26 million in 2014 to $195.71 million in 2023, and is currently $154.20 million as of their latest financial filing in 2024.

How has Standex International's book value per share changed over the last 10 years?

Over the last 10 years, Standex International's book value per share changed from 27.01 in 2014 to 52.43 in 2024, a change of 94.1%.

Related Companies

This page (NYSE:SXI) was last updated on 5/4/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Standex International (SXI) Financials

Frequently Asked Questions About Standex International's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Standex International (SXI) Financials

Annual Income Statements for Standex International

Quarterly Income Statements for Standex International

Annual Cash Flow Statements for Standex International

Quarterly Cash Flow Statements for Standex International

Annual Balance Sheets for Standex International

Quarterly Balance Sheets for Standex International

Annual Metrics and Ratios for Standex International

Quarterly Metrics and Ratios for Standex International

Frequently Asked Questions About Standex International's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools